Much can happen between now and 2023 when actual trial in Delaware appears to be scheduled for jury trial. What makes you think generics will win that civil action?
With S. Ct. announcing that it expects in person arguments to resume this fall, I expect a similar action on part of CAFC here in D.C. I am more optimistic than most that we shareholders will win the Rule 24/60 case now pending in the CAFC; have you read Marjac’s brief?